Literature DB >> 20014257

Injectable treatments for adipose tissue: terminology, mechanism, and tissue interaction.

Adam M Rotunda1.   

Abstract

BACKGROUND: Just as injectable fillers have addressed the need for non-surgical methods to restore desired volume, a number of injectable therapies purpor to play a comparable role to reduce undesired volume.
OBJECTIVE: To review published literature on the history, mechanism of action, and tissue interaction of injectable methods that aim to reduce localized collections of fat.
RESULTS: Mesotherapy is an injection technique that has medical and cosmetic applications and is often confused with injectable fat loss therapies; injection lipolysis describes non-ablative fat reduction with agents (such as beta-agonists) that activate adipocyte lipolytic pathways; and adipolytic therapy using biologic detergents (such as deoxycholate) leads to permanent adipocyte ablation. None of these therapies have been cleared for use in fat reduction by any regulatory authority worldwide.
CONCLUSIONS: The mechanism of action and tissue effects of injectable fat reducing compounds are diverse but are becoming increasingly understood. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20014257     DOI: 10.1002/lsm.20807

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  14 in total

1.  [Injection lipolysis].

Authors:  K Hoffmann
Journal:  Hautarzt       Date:  2010-10       Impact factor: 0.751

Review 2.  Injection Adipolysis: Mechanisms, Agents, and Future Directions.

Authors:  Shahraam Kamalpour; Keith Leblanc
Journal:  J Clin Aesthet Dermatol       Date:  2016-12-01

3.  Improvement in Jowl Fat Following ATX-101 Treatment: Results From a Single-Site Study.

Authors:  Sachin M Shridharani
Journal:  Plast Reconstr Surg       Date:  2020-01-07       Impact factor: 4.730

4.  Total control of fat cells from adipogenesis to apoptosis using a xanthene analog.

Authors:  Ching-Hsuan Tung; Myung Shin Han; Jianjun Qi
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

5.  Cryolipolysis Does not Modify the Behavior and Recovery of Cardiac Autonomic Modulation.

Authors:  Ana Clara Campagnolo Real Gonçalves Toledo; Allysiê Priscilla de Souza Cavina; Isadora Stefen Seixas; Letícia Rosa de Jesus; Maria Eduarda Leonel Silva; Bruna Garcia Corral de Araújo; Franciele Marques Vanderlei
Journal:  Aesthetic Plast Surg       Date:  2021-08-17       Impact factor: 2.326

6.  Role of mesotherapy in musculoskeletal pain: opinions from the italian society of mesotherapy.

Authors:  Massimo Mammucari; Antonio Gatti; Sergio Maggiori; Alessandro F Sabato
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-13       Impact factor: 2.629

7.  Results from a pooled analysis of two European, randomized, placebo-controlled, phase 3 studies of ATX-101 for the pharmacologic reduction of excess submental fat.

Authors:  James McDiarmid; Jesus Benito Ruiz; Daniel Lee; Susanne Lippert; Claudia Hartisch; Blanka Havlickova
Journal:  Aesthetic Plast Surg       Date:  2014-07-02       Impact factor: 2.326

8.  Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study.

Authors:  B Ascher; K Hoffmann; P Walker; S Lippert; U Wollina; B Havlickova
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-03-08       Impact factor: 6.166

9.  Patient Satisfaction after Upper Extremity Laser Lipolysis without Suction.

Authors:  Brett S Kotlus; Charles Mok
Journal:  Plast Surg Int       Date:  2011-09-22

10.  Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study.

Authors:  B Rzany; T Griffiths; P Walker; S Lippert; J McDiarmid; B Havlickova
Journal:  Br J Dermatol       Date:  2014-02       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.